Marotta Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
14,641
-2,012
| -12% | -$139K | 0.2% | 53 |
|
|
2025
Q1 | $1.98M | Buy |
16,653
+565
| +4% | +$67.3K | 0.39% | 46 |
|
|
2024
Q4 | $1.41M | Sell |
16,088
-565
| -3% | -$49.4K | 0.29% | 50 |
|
|
2024
Q3 | $1.98M | Sell |
16,653
-272
| -2% | -$32.4K | 0.39% | 46 |
|
|
2024
Q2 | $2.46M | Sell |
16,925
-301
| -2% | -$43.8K | 0.51% | 39 |
|
|
2024
Q1 | $2.21M | Sell |
17,226
-118
| -0.7% | -$15.2K | 0.46% | 41 |
|
|
2023
Q4 | $1.79M | Sell |
17,344
-156
| -0.9% | -$16.1K | 0.39% | 41 |
|
|
2023
Q3 | $1.59M | Sell |
17,500
-278
| -2% | -$25.3K | 0.37% | 42 |
|
|
2023
Q2 | $1.44M | Buy |
+17,778
| New | +$1.44M | 0.32% | 43 |
|
|
2022
Q4 | $1.21M | Sell |
17,884
-796
| -4% | -$53.9K | 0.29% | 45 |
|
|
2022
Q3 | $931K | Sell |
18,680
-692
| -4% | -$34.5K | 0.24% | 47 |
|
|
2022
Q2 | $1.08M | Sell |
19,372
-2
| -0% | -$112 | 0.27% | 44 |
|
|
2022
Q1 | $1.08M | Sell |
19,374
-2,412
| -11% | -$134K | 0.25% | 47 |
|
|
2021
Q4 | $1.22M | Buy |
21,786
+1,600
| +8% | +$89.6K | 0.28% | 43 |
|
|
2021
Q3 | $969K | Sell |
20,186
-38
| -0.2% | -$1.82K | 0.23% | 43 |
|
|
2021
Q2 | $854K | Buy |
20,224
+2,386
| +13% | +$101K | 0.2% | 45 |
|
|
2021
Q1 | $603K | Buy |
+17,838
| New | +$603K | 0.15% | 50 |
|